Related Experiment Video
Updated: Aug 16, 2026

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Body surface dosimetry following re-injection of 111In-leucocytes
1Department of Nuclear Medicine, Kent and Canterbury Hospital, UK.
Insights
Parents receiving indium-111 labelled white blood cells (111In-leucocytes) should limit activity to 10 MBq. This ensures close contact radiation doses to infants remain below 1 mSv, protecting child health.
Area of Science:
- Nuclear Medicine
- Medical Physics
- Pediatric Radiation Safety
Background:
- Indium-111 labelled white blood cells (111In-leucocytes) are used in diagnostic imaging.
- Parental administration of 111In-leucocytes poses potential radiation exposure risks to infants.
- Current UK guidelines recommend limiting contact for patients with residual activity exceeding 20 MBq.
Purpose of the Study:
- To estimate radiation dose to infants from parents administered 111In-leucocytes.
- To determine safe activity levels for 111In-leucocyte injections in parents of young infants.
Main Methods:
- Thermoluminescent dosimeters were placed on the chest walls of eight patients.
- Dose estimation was performed for infants in close contact with parents receiving 111In-leucocytes.
- Radiation exposure was measured at five specific chest wall sites.
Main Results:
- A 20 MBq injection of 111In-leucocytes to a parent resulted in a close contact dose exceeding 1 mSv for the infant.
- Measured doses confirmed findings from a preliminary study.
- The study established a correlation between injected activity and infant radiation exposure.
Conclusions:
- The maximum recommended 111In-leucocyte activity for parents of young infants should be 10 MBq.
- This dosage limit aims to keep infant radiation exposure below 1 mSv.
- Adherence to this guideline enhances pediatric radiation safety during nuclear medicine procedures.
Abstract:
The dose to a young infant cared for by a parent re-injected with 111In-leucocytes was estimated from the exposure of thermoluminescent dosimeters at five sites on the chest wall of eight patients. The UK Guidance Notes recommend that patients with a residual activity exceeding 20 MBq of 111In should avoid non-essential contact with children. The results confirmed those of an earlier preliminary study which showed that re-injection of 20 MBq of 111In-leucocytes to a parent could lead to a close contact dose greater than 1 mSv. It was concluded that the 111In-leucocyte activity administered to a parent of a young infant should not exceed 10 MBq.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Related Concept Videos
Biological Effects of Radiation
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET